Home Life Sciences Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
Article Open Access

Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development

  • Xiaoling Chen , Junmin Zhang , Quanyi Zhao , Li Ding EMAIL logo , Zhengrong Wu , Zhong Jia and Dian He EMAIL logo
Published/Copyright: August 11, 2023

Abstract

With the continuous development of the pharmaceutical industry, people have always paid attention to the safety and effectiveness of drugs, including innovative drugs and generic drugs. For pharmaceutical companies as manufacturers, drug development is a very lengthy process that requires high costs, millions of man-hours, thousands of trials, and the mobilization of hundreds of researchers. Therefore, efforts need to be made to develop drugs with high safety and effectiveness. Drug research and development plays an important role today. Based on this, this article applied computer molecular simulation embedded technology and artificial intelligence technology to drug research and development. First, the problems faced in the research and development of anti-inflammatory disease-dependent tumor drugs were introduced, and then the applications of computer molecular simulation embedded technology and artificial intelligence technology in drug research and development were analyzed. Subsequently, the application of artificial intelligence in drug research and development teaching was analyzed, and a teaching system based on computer molecular simulation embedded technology and artificial intelligence was designed. Finally, the application effects of computer molecular simulation embedded technology and artificial intelligence technology were analyzed, and a feasible conclusion was drawn. The use of computer molecular simulation embedded technology and artificial intelligence technology can greatly improve the efficiency of drug research and development, and the research and development safety of imatinib mesylate has been improved by 7%. On the other hand, it can improve students’ learning interest and stimulate their learning interest, and students’ drug research and development capabilities have been improved. Drug research and development for inflammatory-dependent tumors has good application prospects.

1 Introduction

There are many difficulties in drug research and development, and few people in the field of inflammatory-dependent tumor research have conducted a detailed analysis of drugs, elaborating on the design, synthesis, and mechanism of action of innovative drugs for inflammatory-dependent tumor, which has led to strong obstacles in the development of innovative drugs for inflammatory-dependent tumor. To remedy this defect and let more people understand drug research and development work, it is necessary to use new technologies to analyze drug research and development.

Drug research and development has received widespread attention from the public, and many scholars have made achievements in this field. Mak Kit-Kay discussed the main reasons for the loss rate of new drug approval, the possible ways in which artificial intelligence could improve the efficiency of the drug development process, and the collaboration between pharmaceutical industry giants and artificial intelligence drug research and development companies [1]. Dugger et al. first examined and emphasized the successes and limitations of the early stages of genomics in drug research and development. He then reviewed the current major efforts in precision medicine and discussed the potential wider uses of mechanically guided therapy in the future [2]. Chaikuad reviewed the latest developments in this rapidly growing area of kinase drug development and highlighted the unique opportunities and challenges of this strategy [3]. Devine discussed some key drivers and scientific developments that were expanding the application of biocatalysis in the pharmaceutical industry, and highlighted potential future developments that might continue to increase the impact of biocatalysis in drug development [4]. Kraus described the salient features of biomarker discovery, analytical validation, clinical identification, and utilization to understand the development process of biomarkers. He also conveyed his understanding of its potential advantages and limitations through this understanding [5]. Weissig analyzed the etiology and pathogenesis of mitochondrial diseases over the past two decades and applied them to the design and development of new experimental drugs for treating mitochondrial diseases [6]. Cochran et al. reviewed the current status of the biology and clinical development of bromine domain and extracellular inhibitors, and discussed the next wave of bromine domain inhibitors with clinical potential in oncology and nononcology indications [7]. The application of drug research and development is rarely studied in inflammatory-dependent tumors.

Artificial intelligence technology has excellent application effects in the field of drug research and development. Fleming explored how artificial intelligence could change drug development [8]. Schneider introduced the views of different international expert groups on the “significant challenges” of artificial intelligence small molecule drug research and development and the methods to solve these problems [9]. Chan believed that the combination of artificial intelligence and new experimental technologies was expected to make the search for new drugs faster, cheaper, and more effective. He discussed the emerging applications of artificial intelligence in improving the drug development process [10]. Yang comprehensively described these machine-learning technologies and their applications in pharmaceutical chemistry [11]. He reviewed some key practical issues surrounding the implementation of artificial intelligence in existing clinical workflows, including data sharing and privacy, transparency of algorithms, data standardization and interoperability across multiple platforms, as well as attention to patient safety [12]. Stephenson understood the current situation of machine-learning technology in the academic and industrial environment of drug research and development, and discussed its potential future applications and several interesting models of machine-learning technology in the field of drug research and development [13]. Harrer explained how to use the latest advances in artificial intelligence to reshape the key steps of clinical trial design to improve the trial success rate [14]. Artificial intelligence technology has rarely been studied in combination with computer molecular simulation embedded technology.

To improve the effectiveness of innovative drug research and development for inflammatory-dependent tumors, this article applied computer molecular simulation embedded technology and artificial intelligence technology to drug research and development. Four typical antitumor drugs were selected to analyze their application effects, and five students who studied the design, synthesis, and mechanism of action of innovative inflammatory-dependent tumor drugs were selected to analyze their teaching effects. Finally, it was concluded that the use of computer molecular simulation embedded technology and artificial intelligence technology can greatly improve the application and teaching effectiveness of drug research. Compared with other people’s experiments, this article combined computer molecular simulation embedded technology and artificial intelligence technology to apply.

2 Problems faced by the research and development of anti-inflammatory-dependent tumor drugs

The problems faced by the research and development of anti-inflammatory-dependent tumor drugs include competition among peers, lack of clinical research, and lax supervision, as shown in Figure 1.

Figure 1 
               Problems faced in the development of anti-inflammatory-dependent oncology drugs.
Figure 1

Problems faced in the development of anti-inflammatory-dependent oncology drugs.

2.1 Serious homogenization and circuit congestion

Currently, the research and development of anti-inflammatory tumor drugs is facing serious homogenization and the threat of race track congestion, and there is a relatively detailed division of anti-inflammatory tumor drugs in different race tracks. Moderate competition between these pathways is beneficial to the development of drug research and development, not only stimulating research and development and promoting industrial development but also promoting the reduction of drug prices and thus benefiting patients. However, issues such as pseudo-innovation, crowdsourcing, and low-level repetitive construction still require high attention from relevant sectors.

2.2 Level of clinical research needs to be further improved

After the standardized development of drug review and approval reform, clinical trial capabilities have made great progress. However, it should be clearly recognized that clinical trials are transitioning from generic drugs to innovative drugs, and there is still a significant gap between the level of clinical trials of new inflammatory-dependent tumor drugs and the level of clinical trials in developed countries. In key clinical stages, the selection of control drugs is unreasonable, and there is a lack of understanding of real-world research. The selection and evaluation of clinical endpoints is not scientific, and the participation and attendance rate of international multicenter clinical trials are not high. The application of modern research models/tools is relatively late, and the selection of research populations lacks scientific nature.

Clinical trials are one of the most critical steps in the development of innovative drugs, as well as an important step in transforming the biological determinants of cancer into treatment options, providing the most convincing and reliable evidence for the safety and effectiveness of drugs. If clinical trials cannot be further improved to meet international standards and comply with the current trend of slowing tumor growth, it may not only affect the smooth and efficient development of new drugs, especially in the field of anticancer drug development, but will also challenge many scientific and ethical issues for a long time.

2.3 Rapid development of emerging technologies has brought many challenges to regulatory authorities

Innovation is the core of research and development. In recent years, the emergence of cell and gene therapy technologies, new drug delivery technologies, and other innovative technologies has changed the concept and regulatory evaluation of new inflammatory-dependent tumor drugs, triggering a new round of research and development boom, and the global pharmaceutical landscape has undergone significant changes. Unlike chemical drugs and ordinary biological agents, they differ significantly from other existing drugs in terms of product manufacturing, process complexity, in vivo biological characteristics and safety risks, as well as personalized use, which poses many challenges and significant regulatory uncertainty. Due to this disruptive application technology being at the forefront of life science research, academia, industry, and regulatory agencies have reached a stage where they do not fully understand the laws of basic theoretical research, transformation research, and clinical application. How to promote innovation from the beginning, how to manage the scientific conduct of drug development and clinical drug trials in a reasonable manner, taking into account the needs of patients, and how to address the challenges posed by these new technologies are requirements of the existing regulatory framework and the technical evaluation system. The key challenge for regulators in this field is to scientifically evaluate and regulate the products of these new technologies.

3 Application of computer molecular simulation embedded technology and artificial intelligence technology in drug research and development

3.1 Application of computer molecular simulation embedded technology

The gradual development of computer molecular simulation embedded technology and artificial intelligence technology has brought drug development into the stage of rational drug design. Based on the results of biochemistry, molecular biology, genetics, computer science, and computational chemistry, potential targets for drug design such as enzymes, receptors, and ion channels have been identified, and the chemical structures of ligands or natural substrates belonging to other categories have been taken into account to rationally develop drugs.

The technology of using computer graphics for molecular modeling is called computer molecular simulation embedded technology. Computer molecular simulation embedded technology uses computers to construct, represent, and analyze molecular models to visualize molecular structures, and simulates the three-dimensional conformation of molecules to visualize the interactions between small drug molecules and biomacromolecules. By identifying potential active sites where small drug molecules bind to receptor macromolecules, the structure of small molecules is modified to find better solutions for improving drug design, making drug research and development intuitive and insightful [15].

Computer molecular simulation embedded technology can provide information about molecular docking: three-dimensional structure of molecules, physical and chemical properties of molecules, structural comparisons between molecules, conformational changes of molecules, flexibility and kinetic properties, and the shape of drug target complexes. Therefore, by using molecular modeling, we can observe and analyze three-dimensional molecular models, and study the adaptability and interaction between drugs and targets, which is an important tool for studying the three-dimensional structure of molecules and using molecular docking to study targets and precursors.

The computer molecular simulation embedded technology in virtual drug screening can effectively improve the current technical status of drug screening. The so-called virtual filtering is a computer-based filtering technology. In this technology, preliminary computer screening greatly reduces the number of drug molecules that need to be screened in reality, enhancing the search for lead compounds. Virtual screening can be used to predict the potential activity of drug molecules, detect potential compounds, and develop collections of compounds with appropriate characteristics. It represents the virtualization of experimental models and has become a new method and technology for innovative drug research and development [16].

Molecular modeling software is used to simulate interactions between biomacromolecules and their precursors, and to study “descriptors” such as electrostatic field, hydrophobic field, hydrogen bond distribution, general conformation, and chemical structural characteristics of drug binding sites. Descriptors are used to calculate and analyze the affinity and binding properties between two substances to optimize and modify conductive compounds, so as to improve drug–receptor interactions and drug bioavailability, and ultimately make them candidates for drugs.

3.2 Application of artificial intelligence technology in drug research and development

As a branch of computer science, artificial intelligence is mainly used to simulate and expand the functions of the human brain. It can be understood as a computer system with human knowledge and behavioral awareness. It can use its own learning and reasoning abilities to solve complex problems to gain experience in solving them and form memories, thereby better understanding human natural language. Artificial intelligence can become a solution for people to take specific actions when encountering events that trigger reactions or when considering complex issues and making decisions. The process of human problem-solving is formalized using graphical methods. Through computer algorithms and programming, computers learn to use this method to solve more complex problems. This set of hardware and software systems used to solve problems is called artificial intelligence. Artificial intelligence is not a finished product, but a continuously evolving technology aimed at using machines to help humans solve problems.

Artificial intelligence technology is widely used in systems biology to predict disease targets, analyze large amounts of data, and establish process models. Because target discovery is a branch of molecular biology research, artificial intelligence technology is not the core of finding new targets, but its important role in target discovery is undeniable.

The application of artificial intelligence models in drug research and development faces many challenges in data preprocessing, model selection, and result evaluation. Current artificial intelligence models, especially deep learning models, often require a large number of labeled samples for training, and the requirements for labeled samples are very high. The obtaining of labeled samples in biomedical and drug research and development requires professional knowledge and experimental validation, which is costly. One of the earliest applications of deep learning in biomedicine is to read images from pathological sections. This is because hierarchical deep learning models are very suitable for learning low-level features of samples such as images. By using hierarchical e-learning, deep learning technology can automatically learn high-level image features, thereby avoiding the trouble of manual feature suggestions to a certain extent.

There is also the problem of labeling samples in medical research, but it is very different from pathological images. Data collected in medical research range from high-throughput histological data to various phenotypic and textual data. The integration and analysis of multiple heterogeneous high-dimensional data sources can compensate for problems at the small sample level of a single data source. The technological trend of artificial intelligence is shifting from traditional large sample learning to small sample learning and feedback learning.

There are different methods and technologies at different stages of drug research and development, and each stage has its own advantages and disadvantages. Artificial intelligence technology can be applied to all stages of drug development, including target screening, small molecule screening, design stage, synthesis, and prevalidation. Artificial intelligence technology is gradually getting rid of the traditional targeted research and development model. In the face of massive and heterogeneous data from multiple sources, artificial intelligence technology is increasingly data oriented.

4 Application of artificial intelligence in drug research and development teaching

Artificial intelligence is essentially the science and technology that provides knowledge and enhances computer learning capabilities, and the results of which can then be used for medical training. Technologies related to artificial intelligence include decision support systems, knowledge representation, machine learning, artificial neural networks, data mining, expert systems, and many other fields. Among them, expert systems, machine learning, and intelligent decision support systems are more commonly used in medical education.

In the past decade, many complex educational problems have been solved or partially solved by artificial intelligence, including language processing, reasoning, planning, and cognitive modeling. Artificial intelligence enables students to participate in learning in a digital and dynamic manner, which is often impossible in outdated textbooks or fixed classroom environments. Through this collaborative learning approach, each student has the potential to promote the development of others and accelerate the exploration of new knowledge and the development of innovative technologies. Specific applications are summarized in Figure 2.

Figure 2 
               Application of artificial intelligence in teaching drug discovery and development.
Figure 2

Application of artificial intelligence in teaching drug discovery and development.

4.1 Virtual online learning platform

Medical training includes theoretical teaching and clinical practice, so medical students studying inflammatory-dependent tumor drugs need to learn correct clinical techniques while cultivating clinical thinking. Artificial intelligence and big data platforms are used to establish scientific models and methods to evaluate clinical reasoning abilities, which are crucial in medical teaching and practice, and can also be understood as virtual practice. Learning tasks are usually set according to the learning objectives and individualized learning plans of medical institutions and practitioners. Students can interview, examine, assist, diagnose, and treat virtual patients. Then, through interviewing patients, relevant medical reports are obtained, and the condition and plan treatment are determined based on the medical reports. Virtual practice makes learning more active, independent, and diverse.

The emergence of online virtual learning systems not only can rapidly cultivate the ability of medical students in school to solve clinical problems but also can save learning costs, improve learning quality and efficiency, and achieve the sharing of high-quality learning resources. In addition to rapidly cultivating the clinical problem-solving abilities of medical students studying inflammatory-dependent tumor drugs, the virtual online learning system also helps to save teaching costs, improve teaching quality and efficiency, and achieve the sharing of high-quality learning resources.

4.2 Virtual training system

The cultivation of medical students studying inflammatory-dependent tumor drugs is inseparable from their practical training, and a good diagnostic foundation is crucial for their future clinical work. The emergence of virtual learning systems can solve the tedious and inactive teaching problems of medical students studying inflammatory-dependent tumor drugs and improve the quality of clinical skill training. Modern, minimally invasive, personalized surgery is attracting great interest. Students can also use this platform to conduct virtual anatomical exercises, simulate different surgical techniques, and create surgical plans. The use of virtual reality technology is crucial for teaching combining surgical and nonsurgical skills, and improving basic surgical skills while teaching specific surgical actions. Medical students studying inflammatory-dependent tumor drugs are able to practice their surgical skills and experience surgical stress and real situations during virtual surgery, which improves the effectiveness of learning.

4.3 Intelligent robot

The application of robotics in the medical field is rapidly developing into a new industry, and it is increasingly common to assist surgeons in surgery. The use of robots and virtual reality scenes can also help students conduct surgical training, allowing them to obtain practical training without endangering patients. Robots with artificial intelligence are accurate, stable, and efficient, and can simulate clinical operations based on data analysis to demonstrate correct surgical operations to medical interns.

4.4 Supporting scientific research

Scientific research requires artificial intelligence technology to extract large amounts of data. Big data are divided into structured data and unstructured data. Structured data, or inline data, are stored in a database and can be logically represented using a two-dimensional table structure. Unstructured data, including all formats of office files, text, images, various reports, images, and audio/video information, are not simple. The analysis of these data is not simple and requires artificial intelligence technology.

5 Teaching system based on computer molecular simulation embedded technology and artificial intelligence

Teaching systems based on computer molecular simulation embedded technology and artificial intelligence are divided into content modules, student modules, professional teacher modules, and expert modules, as shown in Figure 3.

Figure 3 
               Framework of the teaching system.
Figure 3

Framework of the teaching system.

5.1 Content module

The knowledge in the content module is selected from the database by an expert system, mainly including students’ learning content and teachers’ teaching strategies, guiding the entire teaching process. The learning content includes knowledge content, exercises, and exam content for various disciplines. The content of teaching strategies includes teaching strategies for different teaching periods and is combined with the content of the learner module to develop personalized learning plans for students.

5.2 Student module

The student module is the way students use the system. The teaching system is based on molecular computer simulation technology and artificial intelligence, and can record and evaluate students’ learning. Its main function is to collect, record, and analyze information about students’ use of student modules; identify their current strengths and weaknesses in learning; and explain and adjust teaching based on students’ needs. Students’ learning models are established and updated to provide a basis for further teaching. Student learning is recorded, and students are evaluated as a whole.

5.3 Professional teacher module

The professional teacher module is mainly used by teachers in the teaching process to guide their work. The knowledge in this module mainly involves teaching strategies. Its main function is to select the optimal teaching strategy based on actual teaching needs and teaching content based on the teaching strategy, read out module information to students, and view students’ learning models. According to the model, it is judged which aspects of knowledge the students lack, so as to modify the teaching strategy and improve the teaching method.

5.4 Expert module

The expert module is the core of a learning system based on embedded molecular simulation and artificial intelligence technology, with professional knowledge in education and the ability to answer teaching questions, which can promote learning. Its main functions include the following aspects. First, it reads the student learning information in the student module and selects the most suitable teaching method for each student through intelligent data analysis and reasoning. It can compare and analyze students’ interests and learning habits, and infer their knowledge needs and common mistakes. The learning level of students can be scientifically evaluated, and targeted learning content and teaching methods can be designed. The reasons for students’ errors are comprehensively analyzed and corresponding improvement suggestions are proposed. By utilizing the information from the knowledge base, learning content is formulated according to teaching needs, and the professional and systematic knowledge module content is provided for students to learn and use.

Learning systems based on artificial intelligence differ greatly in knowledge content, teaching strategies, and methods. In learning systems based on computer embedded molecular simulation technology and artificial intelligence, expert modules are constructed to focus on learners’ differences and appropriately evaluate learners’ performance differences in the learning system, thereby enabling learners to learn more effectively. In a learning system based on computer molecular simulation technology and artificial intelligence, the role of a teacher has shifted from being a knowledge imparter and mentor to being a teacher guiding students’ learning. Its main role has shifted from preparing and delivering lessons in the classroom to organizing the learning process, guiding learning habits, and providing the necessary learning environment.

6 Application effects of computer molecular simulation embedded technology and artificial intelligence technology

6.1 Application effects of drug research and development

In this article, four typical inflammatory-dependent tumor drugs were selected to analyze the effectiveness of drug research and development from the perspective of efficiency and safety. The basic information of the selected drugs is presented in Table 1.

Table 1

Application effects of drug development

Selected drugs Effectiveness
Cyclophosphamide Influence on DNA structure
Methotrexate Affects nucleic acid biosynthesis
Docetaxel Antimitotic
Imatinib mesylate Based on tumor cell signaling

6.1.1 Efficiency of drug research and development

The efficiency of drug research and development plays a crucial role in the analysis and utilization of drugs. Only by promptly developing drugs that are suitable for patients can they promote their recovery and achieve good therapeutic effects. Based on this, this article used traditional drug research and development methods and used computer molecular simulation embedded technology and artificial intelligence for comparative analysis of drug research methods. The results are presented in Figure 4.

Figure 4 
                     Efficiency of drug development using different methods. (a) Efficiency of drug research using traditional methods. (b) Efficiency of drug research using computerized molecular simulation embedded technology and artificial intelligence.
Figure 4

Efficiency of drug development using different methods. (a) Efficiency of drug research using traditional methods. (b) Efficiency of drug research using computerized molecular simulation embedded technology and artificial intelligence.

Figure 4a represents the efficiency of drug research and development using traditional methods, and Figure 4b represents the efficiency of drug research using computer molecular simulation embedded technology and artificial intelligence. Using traditional methods, the efficiency of cyclophosphamide research and development was 64%, that of methotrexate research and development was 57%, that of docetaxel research and development was 62%, and that of imatinib mesylate research and development was 59%. However, after using computer molecular simulation embedded technology and artificial intelligence technology, the efficiency of cyclophosphamide research and development was 71%, that of methotrexate research and development was 63%, that of docetaxel research and development was 68%, and that of imatinib mesylate research and development was 64%, which was significantly improved compared to using traditional methods. It can be seen that the combination of computer molecular simulation embedded technology and artificial intelligence technology can greatly improve the efficiency of drug research and development.

6.1.2 Safety of drug research and development

Drug research and development needs to focus on safety issues, as dangerous chemicals and instruments are often used in the process of drug research and development, so it is necessary to study the safety of drug research and development. This article analyzed the safety of drug research and development. The results are shown in Figure 5.

Figure 5 
                     Safety of drug research and development using different methods. (a) Safety of drug research and development using traditional methods. (b) Safety of drug research and development using computer molecular simulation embedded technology and artificial intelligence.
Figure 5

Safety of drug research and development using different methods. (a) Safety of drug research and development using traditional methods. (b) Safety of drug research and development using computer molecular simulation embedded technology and artificial intelligence.

Figure 5a represents the safety of drug research and development using traditional methods, and Figure 5b represents the safety of drug research and development using computer molecular simulation embedded technology and artificial intelligence. The research and development safety of cyclophosphamide has increased from 52% using traditional methods to 57% using computer molecular simulation embedded technology and artificial intelligence technology, increasing by 5%. The research and development safety of methotrexate has increased from 58% using traditional methods to 64% using computer molecular simulation embedded technology and artificial intelligence technology, increasing by 6%. The research and development security of docetaxel has increased from 64% using traditional methods to 69% using computer molecular simulation embedded technology and artificial intelligence technology, increasing by 5%. The research and development safety of imatinib mesylate has increased from 67% using traditional methods to 74% using computer molecular simulation embedded technology and artificial intelligence technology, increasing by 7%. It can be seen that the research and development safety of imatinib mesylate has improved fastest.

6.2 Teaching effects of drug research and development

The teaching effect of drug research and development selected medical students from A University who are studying inflammatory-dependent tumors as the subjects of investigation to analyze their drug research and development abilities and drug learning interests. Five students were selected from the survey as representatives for the analysis. This article used a scoring system for the survey of students, with a full score of 100 points.

6.2.1 Student’s interest in drug learning

Interest is the best teacher for learning. Whether students can improve or make progress mainly depends on whether they have interest in learning. This article investigated students’ interest in drug learning, which is presented in Figure 6.

Figure 6 
                     Drug learning interest of students using different methods. (a) Drug learning interest of students using traditional methods. (b) Drug learning interest of students using computerized molecular simulation embedded technology and artificial intelligence.
Figure 6

Drug learning interest of students using different methods. (a) Drug learning interest of students using traditional methods. (b) Drug learning interest of students using computerized molecular simulation embedded technology and artificial intelligence.

Figure 6a represents the drug learning interests of students using traditional methods, and Figure 6b represents the drug learning interests of students using computer molecular simulation embedded technology and artificial intelligence. When using traditional drug research and development methods, each student’s drug learning interest score did not exceed 70 points. However, after using computer molecular simulation embedded technology and artificial intelligence technology, each student’s drug learning interest score exceeded 70 points. It shows that the use of computer molecular simulation embedded technology and artificial intelligence technology can greatly improve students’ learning interest and stimulate their learning interest.

6.2.2 Student’s drug research and development capabilities

The most important thing for students to learn about drug research and development is to improve their drug research and development capabilities and encourage them to independently conduct drug research and development. Based on this, this article analyzed students’ drug research and development capabilities. The results are shown in Figure 7.

Figure 7 
                     Drug development ability of students using different methods. (a) Drug development ability of students using traditional methods. (b) Drug development ability of students using computerized molecular simulation embedded technology and artificial intelligence.
Figure 7

Drug development ability of students using different methods. (a) Drug development ability of students using traditional methods. (b) Drug development ability of students using computerized molecular simulation embedded technology and artificial intelligence.

Figure 7a represents the drug research and development capabilities of students using traditional methods, and Figure 6b represents the drug research and development capabilities of students using computer molecular simulation embedded technology and artificial intelligence. When conducting drug research using traditional drug research methods, Student 5 had the strongest drug research and development ability, with 69 points, while Student 2 had the weakest drug research and development ability, with only 52 points, with a difference of 17 points. However, after using computer molecular simulation embedded technology and artificial intelligence technology, each student’s drug research and development ability has improved, and the difference between the strongest and the weakest was only nine points. This indicates that the gap in drug research and development capabilities among students is gradually decreasing. Overall, students’ drug research and development abilities have been improved by adopting computer molecular simulation embedded technology and artificial intelligence technology.

7 Conclusions

To improve the application effect and teaching effect of drug research and development, this article used computer molecular simulation embedded technology and artificial intelligence technology to apply it to the process of drug research and development. At the same time, the experiment was designed to compare and analyze traditional drug research methods and drug research methods using computer molecular simulation embedded technology and artificial intelligence technology. The analysis was conducted from the perspective of the application effect of drug research and the teaching effect of drug research and development, and finally, a feasible conclusion was reached. The use of computer molecular simulation embedded technology and artificial intelligence technology, compared to traditional drug research methods, not only can improve the efficiency and safety of drug research and development but also can improve students’ learning interest and cultivate their drug research and development capabilities. It can be seen that the use of computer molecular simulation embedded technology and artificial intelligence technology can greatly improve the application and teaching effectiveness of drug research.

  1. Funding information: This work was supported by the National Science and Technology Ministry (2017ZX09101001), Gansu Science and Technology Fund Grant (17ZD2FA009 and 18JR3RA417), Lanzhou Science and Technology Bureau Program Funds (2021–1-141, 2021-RC-86), and the fund grant of NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine (2021GSMPA-KL11 and 2021GSMPA-AJ01).

  2. Conflict of interest: Authors state no conflict of interest.

  3. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019 Mar 1;24(3):773–80.10.1016/j.drudis.2018.11.014Search in Google Scholar PubMed

[2] Dugger SA, Platt A, Goldstein DB. Drug development in the era of precision medicine. Nat Rev Drug Discovery. 2018 Mar;17(3):183–96.10.1038/nrd.2017.226Search in Google Scholar PubMed PubMed Central

[3] Chaikuad A. The cysteinome of protein kinases as a target in drug development. Angew Chem Int Ed. 2018;57(16):4372–85.10.1002/anie.201707875Search in Google Scholar PubMed

[4] Devine PN. Extending the application of biocatalysis to meet the challenges of drug development. Nat Rev Chem. 2018;2(12):409–21.10.1038/s41570-018-0055-1Search in Google Scholar

[5] Kraus VB. Biomarkers as drug development tools: discovery, validation, qualification and use. Nat Rev Rheumatol. 2018;14(6):354–62.10.1038/s41584-018-0005-9Search in Google Scholar PubMed

[6] Weissig V. Drug development for the therapy of mitochondrial diseases. Trends Mol Med. 2020;26(1):40–57.10.1016/j.molmed.2019.09.002Search in Google Scholar PubMed

[7] Cochran AG, Conery AR, Sims IIIRJ. Bromodomains: a new target class for drug development. Nat Rev Drug Discovery. 2019;18(8):609–28.10.1038/s41573-019-0030-7Search in Google Scholar PubMed

[8] Fleming N. How artificial intelligence is changing drug discovery. Nature. 2018;557(7706):S55–5.10.1038/d41586-018-05267-xSearch in Google Scholar PubMed

[9] Schneider P. Rethinking drug design in the artificial intelligence era. Nat Rev Drug Discovery. 2020;19(5):353–64.10.1038/s41573-019-0050-3Search in Google Scholar PubMed

[10] Chan HCS. Advancing drug discovery via artificial intelligence. Trends Pharmacol Sci. 2019;40(8):592–604.10.1016/j.tips.2019.06.004Search in Google Scholar PubMed

[11] Yang. X. Concepts of artificial intelligence for computer-assisted drug discovery. Chem Rev. 2019;119(18):10520–94.10.1021/acs.chemrev.8b00728Search in Google Scholar PubMed

[12] He J. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019;25(1):30–6.10.1038/s41591-018-0307-0Search in Google Scholar PubMed PubMed Central

[13] Stephenson N. Survey of machine learning techniques in drug discovery. Curr Drug Metab. 2019;20(3):185–93.10.2174/1389200219666180820112457Search in Google Scholar PubMed

[14] Harrer S. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40(8):577–91.10.1016/j.tips.2019.05.005Search in Google Scholar PubMed

[15] Steinberg GR, Carling D. AMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discovery. 2019;18(7):527–51.10.1038/s41573-019-0019-2Search in Google Scholar PubMed

[16] Trenfield SJ. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018;39(5):440–51.10.1016/j.tips.2018.02.006Search in Google Scholar PubMed

Received: 2023-06-05
Revised: 2023-07-04
Accepted: 2023-07-11
Published Online: 2023-08-11

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0675/html
Scroll to top button